Table 2.
Clinical features and glycemic parameters by the FABP2 genotypes
| AA | AT/TT | ||||
| Mean (n) | (95% CI) | Mean (n) | (95% CI) | ||
| N | 24 | 31 | |||
| Gender | F/M | 15/9 | 14/17 | ||
| Age | year | 28 | (26,31) | 27 | (25,29) |
| Body mass index1 | kg/m2 | 23.99 | (22.52,25.56) | 24.42 | (23.03,25.90) |
| Waist-hip ratio1 | cm/cm | 0.80 | (0.76, 0.84) | 0.80 | (0.77, 0.83) |
| Systolic blood pressure | mmHg | 112 | (109,116) | 116 | (112,120) |
| Diastolic blood pressure | mmHg | 68 | (65,71) | 68 | (65,70) |
| Triglycerides | mg/dL | 89 | (66,110) | 73 | (57,89) |
| Total cholesterol | mg/dL | 166 | (152,180) | 152 | (141,163) |
| HDL cholesterol | mg/dL | 50 | (45,54) | 48 | (43,54) |
| LDL cholesterol | mg/dL | 98 | (85,111) | 89 | (79,99) |
| Oral glucose tolerance test | |||||
| Fasting plasma glucose | mM | 4.68 | (4.53, 4.83) | 4.75 | (4.62,4.89) |
| Fasting plasma insulin1,2 | pM | 55 | (48,63) | 65 | (59,72) |
| %B1 | 139 | (118,163) | 150 | (132,171) | |
| %S1,3 | 0.63 | (0.54, 0.73) | 0.52 | (0.47, 0.58) | |
1 geometric means; 2 p = 0.0444; 3 p = 0.0461.